FDG Uptake and Lung Blood Flow in PAH Before and After Treatment With Ambrisentan
Clinical trial NCT02958358 · WITHDRAWN
Trial details
- NCT number
- NCT02958358
- Sponsor
- Robert Scott Harris, M.D.
- Status
- WITHDRAWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2016-09-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.